Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026: Washington Tuesday, May 6, 2025, 18:00 Hrs [IST] Vanda Pharmaceuticals Inc. (Vanda) anno ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed ...

DelveInsight's 'IGALMI Market Size, Forecast, and Market Insight Report' highlights the details around IGALMI, a sublingual ...

Neurocrine Biosciences, Inc.  today announced the launch of ConnectING with Carnietm, a multimedia awareness campaign in partnership with Grammy-nominated singer-songwriter and mental health advocate, ...

Considering the bioequivalence study of Brexpiprazole Tablets 0.25mg /0.5 mg/1mg/2mg/3mg/4mg, the Subject Expert Committee ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your healthcare provider might prescribe an antidepressant to control your ...

More information: L.H.D. Le et al, Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors, Brain, Behavior, and Immunity (2025).

Can’t breathe without your nasal spray? You’re not alone. But here’s why that quick fix can cause long-term harm.